Dendrite and BOMSS launch updated National Bariatric Surgical Registry
Dendrite Clinical Systems and the British Obesity & Metabolic Surgery Society (BOMSS) have launched Version 2 of the National Bariatric Surgical Registry, which includes several enhancements and changes improving the data collected and reporting.
The NBSR dataset has been refined by the NBSR Committee to include only useful and important data (e.g. inclusion of HBA1c). For example, Version 2 now records all complications that might occur (Version 1 was limited to four) and also notes the severity of post-op complications using the Clavien-Dindo classification.
Regarding procedures and devices, the NBSR now has an updated the list of device descriptions to match the latest staplers on the market, accommodates newer procedures with a dedicated section for OAGB/MGB and takes into account the use of gastric balloons so that a subsequent first surgical procedure becomes a Primary Procedure and does not appear as a revision. Furthermore, there is a dedicated subset of paediatric questions, for those centres operating on younger patients, which only appears if the age at operation is below 18 years of age.
The new version has an incorporated Timeline offering a visual representation of surgical events and follow up in a time sequence and highlights key missing data, as well as displaying a Weight Loss hart on screen for each patient to view their timeline.
This latest version is html-5 compliant system, which will run on Safari (for a Mac, iPad or PC), Firefox, Chrome and the latest version of Internet Explorer (Version 10 and above).
In future, there will be a dedicated Patient Reported Outcome Measures (PROMS) section.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


